Top of this page
Skip navigation, go straight to the content

Clinical Studies Overview
 
 

Welcome to our
Clinical Studies section

UCB researchers seek to understand, prevent and treat diseases.
Clinical studies involving healthy volunteers and patients play a vital role in the development of new drugs.



Find out more about a selection of studies

 

Epilepsy - Generalized tonic-clonic seizures - "VALOR" study - SP0982 PGCTS

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects with Idiopathic Generalized Epilepsy.

Recruiting

Status

Drug-resistant epilepsy - "ARISE" study - EP0091

A Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects with Drug-Resistant Epilepsy.

Recruiting

Status

Epilepsy in children - "BELLE" study - EP0065

A Multicenter, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects = 1 Month to < 16 Years of Age with Epilepsy.

Recruiting

Status

Epilepsy in children - "ACHIEVE" study - SP0967

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects with Epilepsy >=1 Month to <4 Years of Age with Partial-Onset Seizures.

Recruiting

Status

Nonradiographic axial spondyloarthritis - "BE MOBILE 1" study - AS0010

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled StudyA Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis.

Recruiting

Status

Ankylosing spondylitis - "BE MOBILE 2" study - AS0011

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis.

Recruiting

Status

Psoratic arthritis - "OPTIMAL" study - PA0010

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Reference (Adalimumab) Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis.

Recruiting

Status

Psoratic arthritis - "BE COMPLETE" study - PA0011

A Multicenter, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis.

Recruiting

Status

Discover more about our clinical studies

image description

 

Disease resources

Epilepsy
Rheumatoid arthritis
Osteoporosis
image description
Parkinson's disease
Restless Legs Syndrome
Psoriatic arthritis
Axial Spondyloarthritis
image description
Lupus
Crohn's disease

Want more information on our clinical studies?

Just contact us!

Phone Number: +1-844-599-2273
Email Address: UCBCares@ucb.com